GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Marvel Biosciences Corp (OTCPK:MBCOF) » Definitions » ROE % Adjusted to Book Value

MBCOF (Marvel Biosciences) ROE % Adjusted to Book Value : 0.00% (As of Oct. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Marvel Biosciences ROE % Adjusted to Book Value?

Marvel Biosciences's ROE % for the quarter that ended in Oct. 2024 was 0.00%. Marvel Biosciences's PB Ratio for the quarter that ended in Oct. 2024 was N/A. Marvel Biosciences's ROE % Adjusted to Book Value for the quarter that ended in Oct. 2024 was N/A.

Marvel Biosciences ROE % Adjusted to Book Value Historical Data

The historical data trend for Marvel Biosciences's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Marvel Biosciences ROE % Adjusted to Book Value Chart

Marvel Biosciences Annual Data
Trend Jul20 Jul21 Jul22 Jul23 Jul24
ROE % Adjusted to Book Value
- - - - -

Marvel Biosciences Quarterly Data
Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Marvel Biosciences's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Marvel Biosciences's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Marvel Biosciences's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Marvel Biosciences's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Marvel Biosciences's ROE % Adjusted to Book Value falls into.


Marvel Biosciences ROE % Adjusted to Book Value Calculation

Marvel Biosciences's ROE % Adjusted to Book Value for the fiscal year that ended in Jul. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

Marvel Biosciences's ROE % Adjusted to Book Value for the quarter that ended in Oct. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Marvel Biosciences ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Marvel Biosciences's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Marvel Biosciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Marvel Biosciences Corp (OTCPK:MBCOF) » Definitions » ROE % Adjusted to Book Value
Comparable Companies
TSXV:IBO XCNQ:ASEP XCNQ:LOBE TSXV:IOT XCNQ:RIZE TSXV:XRTX TSX:APLI XCNQ:MBIO TSXV:QPT XCNQ:BLAB VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY ONC BNTX XKRX:068270
Traded in Other Exchanges
MRVL:Canada
Address
505 - 8th Avenue SW, Suite 420, Calgary, AB, CAN, T2P1G2
Website
https://www.marvelbiotechnology.com
Marvel Biosciences Corp is a life sciences company focused on the discovery and development of a synthetic derivative compound of a known drug. It has developed several new chemical entities, using synthetic chemical derivatives of known, off-patent drugs, that inhibit the A2a adenosine receptor with application to neurological diseases (depression & anxiety, Alzheimer's, ADHD), and the non-neurological conditions of cancer and non-alcoholic steatohepatitis. Marvel is also exploring additional undisclosed targets to expand its asset pipeline.